Cegedim integrates BIOrecos data into Senior+ by Claude Bernard AI
Cegedim has announced a partnership between its Claude Bernard service platform and BIOrecos, the leading database dedicated to supporting medical biology test prescriptions, to integrate its data into Senior+ by Claude Bernard AI.
On January 30, Claude Bernard announced the launch of Senior+ by Claude Bernard AI, an AI assistant designed to support general practitioners during their most complex consultations, particularly those involving elderly patients.
Directly integrated into practice management software (PMS), the Senior+ by Claude Bernard AI assistant allows general practitioners to free up medical time and refocus on their patients.
The direct integration of BIOrecos biological data and reference systems, based on recommendations from health authorities, learned societies, and scientific literature, ensures the relevance and timeliness of the information available to physicians.
Through this new technology, Claude Bernard continues its ambition to put AI at the service of medical information. Senior+ by Claude Bernard AI will be progressively enhanced with new modules, tailored to specific therapeutic areas and practices.
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows:
- Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS);
- Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.;
- other (6%).
France accounts for 91.9% of net sales.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
